These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22569091)

  • 1. The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.
    Liu BA; Engelmann BW; Nash PD
    FEBS Lett; 2012 Aug; 586(17):2597-605. PubMed ID: 22569091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.
    Henriques DA; Ladbury JE
    Arch Biochem Biophys; 2001 Jun; 390(2):158-68. PubMed ID: 11396918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2 Domain Binding: Diverse FLVRs of Partnership.
    Jaber Chehayeb R; Boggon TJ
    Front Endocrinol (Lausanne); 2020; 11():575220. PubMed ID: 33042028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse Binding Mode of Phosphotyrosine Peptides with SH2 Protein.
    Wang R; Leung PYM; Huang F; Tang Q; Kaneko T; Huang M; Li Z; Li SSC; Wang Y; Xia J
    Biochemistry; 2018 Sep; 57(35):5257-5269. PubMed ID: 30091902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.
    Llinaś-Brunet M; Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Betageri R; Cardozo M; Jakes S; Lukas S; Patel U; Proudfoot J; Moss N
    J Med Chem; 1999 Feb; 42(4):722-9. PubMed ID: 10052978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG
    Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.
    Zhou Y; Abagyan R
    Fold Des; 1998; 3(6):513-22. PubMed ID: 9889165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Efficient Semi-supervised Learning Approach to Predict SH2 Domain Mediated Interactions.
    Kundu K; Backofen R
    Methods Mol Biol; 2017; 1555():83-97. PubMed ID: 28092029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.